Issuance of Paid Stock Acquisition Rights
First written in FY2016-Q3. 11 of 15 entries say "Advanced", first in FY2017. Latest entry: 2026-05-14.
No other company in this theme has enough history to compare yet.
- FY2025AdvancedAnnual report
「This was mainly attributable to proceeds of ¥1,120.953 million from the issuance of shares upon the exercise of stock acquisition rights, among other items.」
Fundraising through the exercise of stock acquisition rights progressed, and proceeds from financing activities for the consolidated fiscal year were ¥1,108.555 million. Following the filing, the company also issued the 31st and 32nd Series Stock Acquisition Rights. - FY2025-H1AdvancedAnnual report
「Number of these bonds with stock acquisition rights with an exercise-price adjustment clause exercised during the interim accounting period (units): 52,987; number of shares delivered upon exercise during the interim accounting period (shares): 5,298,700; funds raised through exercise during the interim accounting period (¥ thousands): 777,283」
Exercise of stock acquisition rights and related instruments progressed, with 5,298,700 shares delivered and ¥777.283 million raised during the interim accounting period. - FY2024AdvancedAnnual report
「In November 2024, the company issued the 29th Series Stock Acquisition Rights, with an exercise-price adjustment clause, and the 30th Series Stock Acquisition Rights through a third-party allotment to fund new store openings and construction of an e-commerce site in connection with the expansion of its trading-card business, M&A and capital and business alliances, and joint-business initiatives to expand its healthcare business.」
The company issued the 29th and 30th Series Stock Acquisition Rights and specified the intended use of funds for trading-card business store openings and e-commerce, M&A and capital and business alliances, and joint-business initiatives in the healthcare business. - FY2024-Q2AdvancedAnnual report
「28th Series Stock Acquisition Rights (issued 15 March 2024)」
The company issued 2,000 28th Series Stock Acquisition Rights for consideration, representing 200,000 underlying shares, to 1 outside director and 1 executive officer. The exercise period runs from 1 January 2026 through 31 March 2030. - FY2022AdvancedAnnual report
「24th Series Stock Acquisition Rights (issued 16 June 2022)」
On 16 June 2022, the company issued the 24th Series Stock Acquisition Rights to 30 employees and the 25th Series Stock Acquisition Rights to 1 director. Both series carry exercise conditions based on revenue and net profit for the fiscal years ending September 2023 through September 2025. - FY2021-Q3AdvancedAnnual report
「At a meeting of the Board of Directors held on 26 March 2021, the company resolved to issue the 2nd Series Unsecured Convertible Bond-Type Bonds with Stock Acquisition Rights and the 23rd Series Stock Acquisition Rights. These were issued on 28 April 2021, and their subsequent exercise raised ¥965.181 million and increased stated capital and capital surplus.」
The company issued the 2nd Series Unsecured Convertible Bond-Type Bonds with Stock Acquisition Rights and the 23rd Series Stock Acquisition Rights, raising ¥965.181 million through their subsequent exercise. Stated capital and capital surplus also increased. - FY2021-Q2AdvancedAnnual report
「The issuance of the 2nd Series Unsecured Convertible Bond-Type Bonds with Stock Acquisition Rights and the 23rd Series Stock Acquisition Rights dated 28 April 2021 raised ¥559.841 million. In addition, the partial exercise of the 2nd Series Unsecured Convertible Bond-Type Bonds with Stock Acquisition Rights dated 30 April 2021 increased capital by ¥267.484 million.」
The 2nd Series Unsecured Convertible Bond-Type Bonds with Stock Acquisition Rights and the 23rd Series Stock Acquisition Rights were issued through a third-party allotment to raise funds. Capital also increased through the partial exercise of the bonds. - FY2020AdvancedAnnual report
「Although there were proceeds of ¥173.401 million from the issuance of shares upon the exercise of stock acquisition rights,」
The exercise of the 22nd Series Stock Acquisition Rights raised ¥173.401 million, and fundraising through paid stock acquisition rights continued. - FY2019AdvancedAnnual report
「On 24 September 2019, the group issued the 1st Series Unsecured Convertible Bond-Type Bonds with Stock Acquisition Rights and the 22nd Series Stock Acquisition Rights through a third-party allotment to fund business expansion in the IoT and blockchain fields, M&A and capital and business alliances, advertising and promotional expenses, and repayment of outstanding borrowings, raising a combined ¥1,004.298 million.」
The company issued convertible bond-type bonds with stock acquisition rights and the 22nd Series Stock Acquisition Rights to fund new business areas, M&A and capital and business alliances, advertising and promotional expenses, and repayment of borrowings, raising ¥1,004.298 million. - FY2018AdvancedAnnual report
「This was attributable to proceeds of ¥429.266 million from the issuance of shares upon the exercise of stock acquisition rights and proceeds of ¥349.969 million from the issuance of shares, among other items.」
During the period, 2,760 paid stock acquisition rights were exercised, raising ¥429.266 million. The company also conducted a third-party allotment. - FY2017AdvancedAnnual report
「The company issued stock acquisition rights through a third-party allotment dated 25 September 2017 to fund game-title development costs, advertising and promotional expenses, and M&A and capital and business alliances.」
In addition to its previous issuances of paid stock acquisition rights, the company issued the 16th through 19th Series Stock Acquisition Rights and specified their intended use of funds. - FY2016-Q3First statedAnnual report
「These stock acquisition rights were issued for consideration based on a resolution of the Board of Directors dated 14 April 2016, upon payment of an amount equivalent to their fair value. Because the payment amount was not particularly advantageous to the subscribers, shareholder approval was not required.」
The company issued the 14th and 15th Series Stock Acquisition Rights for consideration and established an incentive scheme based on a resolution of the Board of Directors.